Posted on 3/24/20
Why Raytheon, General Dynamics, and United Technologies Stocks All Fell 10% Today
What happenedCongressional and White House plans to bail out companies crushed by the novel coronavirus and to mail out billions of dollars' worth of relief cash . . .
Posted on 3/24/20
Why Cognex Stock Dropped 10% Today
What happenedOn another down day for stock markets, with the Dow off 3% and the Nasdaq down 0.3%, shares of "machine vision" specialist Cognex (NASDAQ:CGNX) saw . . .
Posted on 3/24/20
CVS Giving Frontline Workers Bonuses, Hiring 50,000 to Meet COVID-19 Needs
As it works to keep its drugstores open and staffed amid the coronavirus pandemic, CVS Health (NYSE:CVS) is rewarding the employees who make that possible with . . .
Posted on 3/23/20
Thermo Fisher Scientific Continues Investments
For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million . . .
Posted on 3/23/20
Stoke Therapeutics Provides Business Updates
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein . . .
Posted on 3/23/20
AlloVir Expands Its Research Collaboration with Baylor College of Medicine
CAMBRIDGE, Mass & HOUSTON--(BUSINESS WIRE)--AlloVir, a late-clinical stage T-cell immunotherapy company, today announced the expansion of its research and development collaboration with Baylor College of Medicine . . .
Posted on 3/23/20
Hoth Therapeutics Announces Agreement to Joint Development of a Self-Assembling Vaccine
NEW YORK, March 23, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has reached an agreement with Voltron Therapeutics, Hoth . . .
Posted on 3/22/20
Peak Physical Therapy & Sports Performance Moves to Virtual Treatment Amid COVID-19 Pandemic
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, has . . .
Posted on 3/20/20
Cerveau Technologies Announces Collaboration with Alector
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced a licensing agreement with Alector, in which Cerveau will provide its investigational imaging agent (MK-6240) to Alector for use in . . .
Posted on 3/20/20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25M with Lincoln Park Capital
CAMBRIDGE, Mass., March 20, 2020 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today . . .
Posted on 3/20/20
Mylan Ramps Up Production of Hydroxychloroquine as a Potential COVID-19 Treatment
Mylan (NASDAQ:MYL) has restarted production of its hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility as a potential treatment for COVID-19, the disease caused by . . .
Posted on 3/20/20
GE Healthcare Boosts Its COVID-19 Efforts
GE Healthcare President and CEO Kieran Murphy issued a statement Thursday detailing the company's efforts to help the world battle the coronavirus pandemic. The unit of . . .
Posted on 3/20/20
Bristol Myers Squibb Hints at Further Acquisition Plans With New Executive Hire
Bristol Myers Squibb (NYSE:BMY) is drawing from the ranks of the finance industry for its latest high-level hire. The company announced Wednesday it has tapped Elizabeth . . .
Posted on 3/20/20
Curis Provides Business Update
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the . . .
Posted on 3/20/20
Tekla Healthcare Opportunities Fund Announces Renewal of Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Tekla Healthcare Opportunities Fund announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows . . .
Posted on 3/20/20
Tarveda Therapeutics and SciClone Pharmaceuticals International Establish Licensing Agreement
WATERTOWN, Mass.--(BUSINESS WIRE)--Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as . . .
Posted on 3/19/20
T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient
LEXINGTON, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it was . . .
Posted on 3/19/20
Tufts Health Plan Foundation Commits $1 Million to Address COVID-19
Tufts Health Plan Foundation announced today it is making an additional $1 million available to efforts driven by community and to nonprofit organizations supporting older people . . .
Posted on 3/19/20
Dragonfly Therapeutics Completes New Investment Round
Dragonfly Therapeutics, Inc. today announced that Fidelity Management & Research Company has led a new round of investment in Dragonfly, along with other major investors. This brings . . .
Posted on 3/19/20
FORMA Therapeutics Announces Divestiture of Select Hit Discovery Capabilities
WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that it has sold select hit discovery capabilities . . .
Posted on 3/19/20
Trump Signs Coronavirus Relief Bill Into Law
After hammering out the details regarding the coronavirus relief package proposed by the Trump administration, the Senate approved the bill on Wednesday, with President Trump signing . . .
Posted on 3/19/20
Cigna Reports Pricing Of $1.45B Of Notes Under Tender Offers
Cigna (NYSE:CI) gives pricing terms for $1.45B of notes tendered under its previously announced tender offers. Total consideration includes $30 early tender payment per $1,000 principal . . .
Posted on 3/19/20
Seres Therapeutics Closes $25M Stock Sales Deal
Seres Therapeutics (NASDAQ:MCRB) inks an agreement with Cowen and Company for the at-the-market sale of up to $25M of its common stock. Cowen will earn a . . .
Posted on 3/18/20
Health Vector and Primetime Medical Software Forge Partnership
Health Vector and Primetime Medical Software announced an exclusive partnership that brings the leading strengths of each company to transform patient engagement through a new class . . .
Posted on 3/18/20
Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today
What happenedShares of several biotechs jumped on Tuesday as the overall stock market rebounded from a major downturn yesterday on reports that a huge federal stimulus . . .

